位置:成果数据库 > 期刊 > 期刊详情页
齐拉西酮对慢性不可预见应激大鼠抑郁行为与海马神经发生的作用
  • ISSN号:1005-3220
  • 期刊名称:临床精神医学杂志
  • 时间:2013
  • 页码:5-7
  • 分类:R749.053[医药卫生—神经病学与精神病学;医药卫生—临床医学]
  • 作者机构:[1]第四军医大学西京医院心身科,西安710032
  • 相关基金:国家自然科学基金项目(81171285)
  • 相关项目:rTMS治疗抑郁症的新机制- - 对髓鞘的保护作用
中文摘要:

目的:研究齐拉西酮对慢性不可预见应激(chronic unpredictable stress,cus)大鼠抑郁样行为的改善作用以及对海马神经发生的作用。方法:将24只大鼠分为对照组(n=8),慢性不可预见应激组(n=8)和齐拉西酮组(Ft=8),建立CUS大鼠模型,连续7d给予齐拉西酮[2.5mg/(kg·d)],通过旷场及糖水摄取实验观察各组动物行为学变化、溴脱氧尿嘧啶核苷(BrdU)掺入实验观察海马增殖情况,蛋白质印迹法(Westernblot)检测海马B细胞淋巴瘤/白血病-2(Bcl-2)、脑源性神经营养因子(BD.NF)和磷酸化细胞外信号调节激酶(pERK1/2)的表达水平的变化。结果:持续21d的慢性不可预见应激抑制了动物对糖水的偏好及单位时间内运动距离(与对照组相比较,P均〈0.05),而给予齐拉西酮可以改善这种现象(与慢性不可预见应激组比较,P均〈0.05);BrdU染色结果显示,齐拉西酮可以显著增加海马的增殖细胞数,而且增加了增殖细胞中的神经元比率(与慢性不可预见应激组比较,P均〈0.05);进一步通过Westernblot发现,CUS应激抑制了大鼠海马Bcl-2、BDNF及pERK1/2的表达(与对照组相比较,P均〈0.05),而给予齐拉西酮则缓解了这一下降现象(与慢性不可预见应激组比较,P均〈0.05)。结论:齐拉西酮能够改善动物模型的抑郁行为,而这一作用可能与其促进海马Bcl-2、BDNF及pERK1/2的表达,进而促进海马神经发生来实现的。

英文摘要:

Objective:To investigate the effect of ziprasidone on the improvement of ethology and neuro- genesis in chronic unpredictable stress (CUS) rats. Method:24 healthy rats were divided into 3 groups at ramdom : Non-CUS + saline ( n = 8 ), CUS + saline ( n = 8 ), CUS + ziprasidone ( n = 8 ), after the establishment of CUS model, rats were received ziprasidone (2.5 mg/kg/day) for 7 days intragastrically. Immediately after CUS or after drug administration ,rats were subjected to sucrose preference testing and open field test. To assess the proliferation of cells, Bromodeoxyuridine (BrdU) was administered before the last behavioral test and ana- lyzed 14 days later, and the expression of B-cell lymphoma 2 (Bcl-2), brain derived neurophic factor (BDNF) and phosphated extracellular signal-regulated kinase (pERK1/2) in hippocampus were determined by Western blot at the end of the last behavioral test. Results:Ziprasidone blocked the reduction of sucrose preference and the total traveling distance ( compared with the CUS + saline group, all P 〈 0.05) which was caused by chronic unpredictable stress ( compared with the Non-CUS + saline group, all P 〈 0.05 ) ; There was a significant increase in the number of hippocampal BrdU + ceils in CUS + ziprasidone than CUS rats ( all P 〈 0.05 ), and the number of cells co-labeled with NeuN, a marker of neurons, and BrdU in the hippocampal dentate gyms (DG) was also significantly higher in the CUS + ziprasidone rats than CUS + saline rats; Furthermore, exposure to CUS resulted in a significant decrease in the expression of pERK1/2, Bcl-2 and BDNF of hippocampus ( all P 〈 0. 05) , and ziprasidone-infused rats ( CUS + ziprasidone) showed significantly increase of the expression of pERK1/2,Bcl-2 and BDNF (compared with the CUS + saline group,all P 〈0. 05). Conclusion:These data suggest that the neurogenesis effect of ziprasidone may play an important role in depression therapy, and this

同期刊论文项目
同项目期刊论文
期刊信息
  • 《临床精神医学杂志》
  • 中国科技核心期刊
  • 主管单位:南京市卫生局
  • 主办单位:南京医科大学附属脑科医院
  • 主编:侯钢
  • 地址:南京市广州路264号
  • 邮编:210029
  • 邮箱:lcjsyx@126.com
  • 电话:025-82296109
  • 国际标准刊号:ISSN:1005-3220
  • 国内统一刊号:ISSN:32-1391/R
  • 邮发代号:28-224
  • 获奖情况:
  • 中国科技论文统计源期刊
  • 国内外数据库收录:
  • 中国中国科技核心期刊
  • 被引量:19116